FindTrial
Sign In

The effect of using medicine dexmedetomidine on pain killer fentanyl requirement in patients undergoing kidney transplantation.

Effect of intraoperative low dose continuous infusion of dexmedetomidine on fentanyl requirement in patients undergoing renal transplantation.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/012913
Enrollment
50
Registered
2018-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- CKD patients on hemodialysis posted for elective renal transplant

Interventions

Intervention1: Dexmedetomidine: Effect of low dose intravenous infusion of dexmedetomidine in dose of 0.2 microgram per kilogram body weight per hour started 10 minutes before induction used throughou

Sponsors

Sir Ganga Ram Hospital New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients undergoing renal transplantation 2. Willing to give informed consent 3. ASA grade 2 and 3

Exclusion criteria

Exclusion criteria: 1. Patient refusal 2. Age below 18 yrs and above 60 yrs 3. Patients undergoing combined Liver-Kidney transplant 4. Patients with hepatic pathology 5. Patients with associated cardiac pathology 6. Patients with poorly controlled psychosis 7. Patients with hypersensitivity to the study drug

Design outcomes

Primary

MeasureTime frame
Dexmedetomidine will decrease the fentanyl requirementTimepoint: 0 15 30 45 60 75 90 105 120 min immediate postoperative period—

Secondary

MeasureTime frame
Sedation. Decreased nausea vomiting. Analgesia.Timepoint: 15 min interval till 2 hours postoperative—

Countries

India

Contacts

Public ContactDr Chopade Mahesh Narsingrao

Sir Ganga Ram Hospital New Delhi.

drkknarani@hotmail.com91-9810465134

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026